123 related articles for article (PubMed ID: 30545141)
1. Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways.
Wang J; Nasser MI; Adlat S; Ming Jiang M; Jiang N; Gao L
Molecules; 2018 Dec; 23(12):. PubMed ID: 30545141
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of Schisandrin B on human prostate cancer cells.
Nasser MI; Han T; Adlat S; Tian Y; Jiang N
Oncol Rep; 2019 Jan; 41(1):677-685. PubMed ID: 30320364
[TBL] [Abstract][Full Text] [Related]
3. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
[TBL] [Abstract][Full Text] [Related]
4. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I.
Fu XQ; Chou JY; Li T; Zhu PL; Li JK; Yin CL; Su T; Guo H; Lee KW; Hossen MJ; Chou GX; Yu ZL
Exp Dermatol; 2018 Feb; 27(2):201-204. PubMed ID: 29078004
[TBL] [Abstract][Full Text] [Related]
5. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
Jorvig JE; Chakraborty A
Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
[TBL] [Abstract][Full Text] [Related]
6. Bigelovin inhibits STAT3 signaling by inactivating JAK2 and induces apoptosis in human cancer cells.
Zhang HH; Kuang S; Wang Y; Sun XX; Gu Y; Hu LH; Yu Q
Acta Pharmacol Sin; 2015 Apr; 36(4):507-16. PubMed ID: 25619393
[TBL] [Abstract][Full Text] [Related]
7. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.
Gu L; Liao Z; Hoang DT; Dagvadorj A; Gupta S; Blackmon S; Ellsworth E; Talati P; Leiby B; Zinda M; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Huszar D; Nevalainen MT
Clin Cancer Res; 2013 Oct; 19(20):5658-74. PubMed ID: 23942095
[TBL] [Abstract][Full Text] [Related]
9. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
10. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling.
Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Takeuchi S; Koeffler HP; Taguchi H
Cancer Sci; 2005 Jul; 96(7):425-33. PubMed ID: 16053514
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
13. The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.
Handle F; Puhr M; Schaefer G; Lorito N; Hoefer J; Gruber M; Guggenberger F; Santer FR; Marques RB; van Weerden WM; Claessens F; Erb HHH; Culig Z
Mol Cancer Ther; 2018 Dec; 17(12):2722-2731. PubMed ID: 30254184
[TBL] [Abstract][Full Text] [Related]
14. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
Gong A; He M; Krishna Vanaja D; Yin P; Karnes RJ; Young CY
Mol Nutr Food Res; 2009 Jul; 53(7):878-86. PubMed ID: 19437484
[TBL] [Abstract][Full Text] [Related]
15. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
17. Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling.
Yang Y; Ikezoe T; Zheng Z; Taguchi H; Koeffler HP; Zhu WG
Int J Oncol; 2007 Sep; 31(3):593-600. PubMed ID: 17671686
[TBL] [Abstract][Full Text] [Related]
18. Chrysanthemum indicum L. extract induces apoptosis through suppression of constitutive STAT3 activation in human prostate cancer DU145 cells.
Kim C; Kim MC; Kim SM; Nam D; Choi SH; Kim SH; Ahn KS; Lee EH; Jung SH; Ahn KS
Phytother Res; 2013 Jan; 27(1):30-8. PubMed ID: 22438130
[TBL] [Abstract][Full Text] [Related]
19. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
[TBL] [Abstract][Full Text] [Related]
20. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
Agarwal C; Tyagi A; Kaur M; Agarwal R
Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
